on Schutzgemeinschaft Der Kapitalanleger E.V.
SdK Offers Litigation Finance to Former STADA Shareholders
SdK Schutzgemeinschaft der Kapitalanleger e.V. is offering litigation finance to former shareholders of STADA Arzneimittel AG. These shareholders, who tendered their shares during the takeover by Nidda Healthcare Holding AG in August or September 2017, are entitled to an additional payment of €8.15 per share. This follows a May 2023 decision by the Federal Court of Justice.
Despite the ruling, Nidda Healthcare has refused voluntary payment. Therefore, SdK provides litigation financing with no cost risk to affected former shareholders. This funding will cover all legal costs in exchange for a 30% profit participation from the proceeds in case of a successful claim.
Information on how to proceed and contact details are available for the former shareholders wishing to enforce their claims. SdK is committed to assisting them throughout the process.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Schutzgemeinschaft Der Kapitalanleger E.V. news